Autres langues Aclaris Therapeutics, Inc.

Actions

ACRS

US00461U1051

Temps réel estimé Cboe BZX Autres places de cotation 21:58:14 02/05/2024			Varia. 5j.	Varia. 1 janv.
1,305 ^USD	+3,57 %		+9,24 %	+23,81 %

19/03	Aclaris Therapeutics, Inc. annonce la démission de membres de son conseil d'administration	CI
27/02	Aclaris Therapeutics, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Aclaris Therapeutics to Announce First Quarter 2024 Financial Results on May 7, 2024 and to Provide Corporate Update	30/04
FLARE THERAPEUTICS APPOINTS DOUGLAS MANION, M.D., FRCP AS CHIEF EXECUTIVE OFFICER	24/04
Aclaris Therapeutics, Inc. Announces Board Resignations	19/03
Aclaris: Q4 Earnings Snapshot	27/02
Aclaris Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27/02
Aclaris Therapeutics, Inc. Announces Intangible Asset Impairment for the Three Months Ended December 31, 2023	27/02
Earnings Flash (ACRS) ACLARIS THERAPEUTICS Posts Q4 Revenue $17.6M	27/02
Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update	27/02
Aclaris Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	27/02
North American Morning Briefing : Stock Futures -2-	21/02
Aclaris Therapeutics, Inc. Announces Termination of Employment of Gail Cawkwell as Chief Medical Officer	05/02
North American Morning Briefing : Stock Futures -2-	23/01
Sector Update: Health Care Stocks Weaker Late Afternoon	16/01
Sector Update: Health Care Stocks Softer Tuesday Afternoon	16/01
Aclaris Therapeutics Shares Rise; Strategic Review Announced, CEO Manion to Step Down	16/01
Aclaris Therapeutics Conducts Strategic Review of Business	16/01
Aclaris Therapeutics Announces Leadership Changes and Strategic Business Review	16/01
Aclaris Therapeutics, Inc. Announces Executive Changes	16/01
Aclaris Therapeutics, Inc. Announces Chief Executive Officer Changes	16/01
North American Morning Briefing : Stock Futures -2-	12/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Aclaris Therapeutics, Inc.

Actions

ACRS

US00461U1051

Autres langues

Filtres